AMRX
AMRX
US03168L1052
Amneal Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 3.018.760.000 2.793.957.000
8.0%
Cost of Revenue 1.905.452.000 1.773.519.000
7.4%
Gross Profit 1.113.308.000 1.020.438.000
9.1%
715.394.000 672.065.000
6.4%
Operating Income 397.914.000 348.373.000
14.2%
Pretax Income 139.209.000 -55.013.000
353.0%
Net Income Common Stockholders 72.057.000 -116.886.000
161.6%
-- --
--
-- --
--
ende